Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
512.65
-1.14 (-0.22%)
At close: Jun 26, 2026, 4:00 PM EDT
512.00
-0.65 (-0.13%)
After-hours: Jun 26, 2026, 4:48 PM EDT
Madrigal Pharmaceuticals Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Madrigal Pharmaceuticals stock have an average target of 680.51, with a low estimate of 513.59 and a high estimate of 964. The average target predicts an increase of 32.74% from the current stock price of 512.65.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Madrigal Pharmaceuticals stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 11 | 11 | 11 | 10 | 10 |
| Buy | 3 | 3 | 3 | 3 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 16 | 16 | 16 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Hold Reiterates $550 → $542 | Hold | Reiterates | $550 → $542 | +5.73% | Jun 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $620 | Buy | Reiterates | $620 | +20.94% | May 28, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $709 → $514 | Buy | Reiterates | $709 → $514 | +0.18% | May 26, 2026 |
| Barclays | Barclays | Buy Reiterates $964 | Buy | Reiterates | $964 | +88.04% | May 8, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $587 → $578 | Buy | Maintains | $587 → $578 | +12.75% | May 7, 2026 |
Financial Forecast
Revenue This Year
1.50B
from 958.40M
Increased by 56.04%
Revenue Next Year
2.21B
from 1.50B
Increased by 47.52%
EPS This Year
-6.52
from -12.73
EPS Next Year
12.38
from -6.52
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.6B | 2.7B | |
| Avg | 1.5B | 2.2B | |
| Low | 1.4B | 1.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 62.2% | 79.2% | |
| Avg | 56.0% | 47.5% | |
| Low | 46.2% | 28.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -6.15 | 16.78 | |
| Avg | -6.52 | 12.38 | |
| Low | -7.11 | 10.01 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.